World Drug Report 2014 Electronic Resource

The World Drug Report provides an annual overview of the major developments in drug markets for the various drug categories, ranging from production to trafficking, including development of new routes and modalities, as well as consumption. Chapter 1 of the World Drug Report 2014 provides a global overview of the latest developments with respect to opiates, cocaine, cannabis and amphetamines (including "ecstasy") and the health impact of drug use. Chapter 2 zeroes in on the control of precursor chemicals used in the manufacture of illicit drugs.

The 2019 World Drug Report will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and supply and provides the reference point for information on the drug situation worldwide.

The World Drug Report provides an annual overview of recent developments for various drug categories. Chapter one of the World Drug Report 2015 provides a global overview of the latest developments with respect to opiates, cocaine, cannabis and synthetic drugs, ranging from production to trafficking as well as consumption and the health impact of drug use. Chapter two focuses on Alternative Development, its relation to illicit cultivation, and also within the broader context of the development agenda.

The World Drug Report 2005 provides one of the most comprehensive overviews of illicit drug trends at the international level. In addition, this year it presents the work of UNODC in two new areas of research: an estimate of the financial value of the world drug market, and the preliminary steps towards the creation of an illicit drug index. The analysis of trends, some going back 10 years or more, is presented in Volume 1. Detailed statistics are presented in Volume 2. Taken together these volumes provide the most up to date view of today's illicit drug situation.

Drawing on the Household Living Arrangements of Older Persons 2019 Dataset, the World Population Ageing 2020 Highlights will document key patterns and trends of the household living arrangements of older persons around the world.

The 2017 WDR will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs as well as highlighting a thematic area of concern. The Report will maintain a global overview of the baseline data and estimates on drug demand and supply. This part will be descriptive and less analytical to fulfill one of the main functions of the report which is to provide the reference point of information on the drug situation worldwide. Other parts will be more analytical and will look in depth at few specific topics. Issues which will be highlighted in analysing new trends were selected on the basis of available research findings discussed within RAB and other internal and external stakeholders, including the members of the WDR Scientific Advisory Committee (SAC). The thematic focus of the 2017 Report will be on the links between drugs, terrorism, corruption, transnational organized crime and illicit financial flows.

The World Drug Report provides an annual overview of the major developments in drug markets for the various drug categories, ranging from production to trafficking, including development of new routes and modalities, as well as consumption. Chapter 1 of the World Drug Report 2014 provides a global overview of the latest developments with respect to opiates, cocaine, cannabis and amphetamines (including “ecstasy”) and the health impact of drug use. Chapter 2 zeroes in on the control of precursor chemicals used in the manufacture of illicit drugs.

The World Drug Report presents a comprehensive overview of the latest developments in drug markets. It covers production, trafficking, consumption and the related health consequences. Chapter 1 of this year's Report examines the global situation and the latest trends in the different drug markets and the extent of illicit drug use, as well as the related health impact. Chapter 2 addresses the issue of precursor control, which has gained in prominence given the growing manufacture of synthetic drugs.